Teriparatide
NDC 0093-1106, Teriparatide, injection, solution, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-1106
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208569
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERIPARATIDE ACETATE250 ug/mL
Pharmacologic classes
Parathyroid Hormone Analog [EPC]; Parathyroid Hormone [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-1106-16 | 00093110616 | 1 SYRINGE in 1 CARTON (0093-1106-16) / 2.24 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d371f0f7-d492-4481-b360-051456d56d65NADAC price for package 00093110616
GET /v1/drugs/nadac/00093110616
Use it
Look up 0093-1106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-1106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-1106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.